View Clinical Trial (Medical Research Study)
Imagery Rescripting for Posttraumatic Nightmares in Rural Operation Enduring Freedom (OEF)/Operation Iraqi Freedom (OIF) Veterans With Posttraumatic Stress Disorder (PTSD) - NCT00837382-77030(Clinical Trial 269235)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Houston |
|
State:
|
|
TX |
| Zip Code: |
|
77030 |
| Conditions: |
|
Stress Disorders, Post-Traumatic - Sleep Disorders |
| Purpose: |
|
Many service members returning from Iraq and Afghanistan have difficulties adjusting back to
civilian life. Research shows that symptoms of posttraumatic stress disorder (PTSD) are
particularly high in returning Operation Enduring Freedom (OEF)/Operation Iraqi Freedom
(OIF) veterans, and that combat-related nightmares and sleep disturbances are common in
veterans with PTSD. This is of concern because people with these problems will often use
unhealthy ways of coping. Although combat-related nightmares and difficulty sleeping are
highly distressing, there are helpful treatments that do not involve taking medication. One
of these treatments teaches specific skills to help people improve their sleep habits and to
change their nightmares so that they are less upsetting. This treatment can be very helpful
and research shows that people experience decreases in the frequency and severity of their
nightmares, decreased symptoms of depression and PTSD, and improved sleep quality and
quantity after completing treatment. However, because this treatment has only been studied
with civilians, it is not clear how well this treatment works for returning veterans. This
study tests how well this treatment works in treating combat nightmares in veterans who also
have PTSD from experiencing a traumatic event.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
Patients for the open trial will be
1. OEF/OIF veterans (aged 18-64);
2. English-speaking;
3. currently enrolled in the Trauma Recovery Program (TRP) at the Michael E. DeBakey
Veteran Affairs Medical Center (MEDVAMC);
4. reporting at least one combat or war zone associated PTNM in the past week;
5. have an existing PTSD International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM); and
6. consenting to be in an open trial for treatment of PTNM. In addition, patients must
agree to allow their assessment and therapy sessions to be video/audiotaped for the
purposes of supervision.
Pilot Study: Patients for the pilot study will be
1. OEF/OIF veterans (aged 18-64);
2. English-speaking;
3. currently enrolled in the Conroe CBOC for their primary or mental health care;
4. reporting at least one combat or war zone associated PTNM in the past week;
5. have an existing PTSD ICD-9-CM diagnosis; and
6. consenting to be in the pilot study for treatment of PTNM. In addition, patients must
agree to allow their assessment and therapy sessions to be video/audiotaped for the
purposes of supervision.
Exclusion Criteria:
Patients will be excluded for the following reasons:
1. current active suicidal/homicidal ideation and intent;
2. current substance dependence;
3. a diagnosis of bipolar or psychosis;
4. active participation in another psychosocial treatment for PTSD;
5. prescribed the medication Prazosin (a psychotropic medication for the treatment of
nightmares).
Patients interested in receiving the intervention will not be excluded if they are taking
psychotropic medication (except for Prazosin) and may continue to take their medication as
prescribed throughout the study. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
September 22, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|